구독하기
연구 모델
서비스
전임상 효능 평가
Resource
B6-hGIPR Mouse
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
B6-hGIPR Mouse
제품명
B6-hGIPR Mouse
제품 ID
C001858
품종 계통
C57BL/6NCya-Giprem1(hGIPR)/Cya
Backgroud
C57BL/6NCya
상태
이 마우스 계통을 논문에서 사용할 경우, “B6-hGIPR Mouse (카탈로그 번호 C001858)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
Metabolic Target Humanized Mouse Models
Obesity and Diabetes Mellitus
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
Metabolic Target Humanized Mouse Models
Obesity and Diabetes Mellitus
기본 정보
관련 자료
기본 정보
유전자명
유전자 별칭
PGQTL2
NCBI ID
염색체
Chr 19
MGI ID
Datasheet
품종 계통 설명
The GIPR gene encodes the gastric inhibitory polypeptide receptor (GIPR), a G protein-coupled receptor with notable expression in pancreatic β-cells, and also detected in the gastrointestinal tract, adipose tissue, and brain [1-2]. The GIPR protein acts as the cognate receptor for gastric inhibitory polypeptide (GIP), a key incretin hormone that potentiates glucose-dependent insulin secretion, thereby regulating systemic glucose homeostasis [2]. While prominently expressed in pancreatic β-cells, GIPR is also present in tissues including the stomach and small intestine [3]. Dysregulation of GIPR function and genetic variants within GIPR have been implicated in metabolic disorders such as type 2 diabetes and obesity, and potentially in the pathogenesis of endocrine tumors and retinoblastoma [4-5]. Emerging evidence suggests a role for GIPR signaling in immunomodulation and inflammation within the gut, highlighting its potential relevance in inflammatory bowel diseases [3]. Currently, therapeutic monoclonal antibodies targeting GIPR are being explored for the treatment of diabetes and obesity. Intriguingly, GIPR may exhibit context-dependent roles within tumor microenvironments, with some evidence suggesting tumor-suppressive functions in specific cancers such as retinoblastoma [4-5]. This multifaceted nature positions GIPR as a compelling therapeutic target for metabolic and inflammatory diseases and potentially selected malignancies.
B6-hGIPR mouse is a humanized model generated using gene editing technology, in which the Exon 3~14 of the coding sequence (CDS) encoding the human GIPR protein and the 3'UTR of mouse Gipr gene are integrated into a specific site within the mouse Gipr gene, while retaining the endogenous gene sequence encoding the murine signal peptide (aa.1~18) and aa.19. This model can be used for studying the pathological mechanisms and therapeutic approaches of metabolic and inflammatory diseases and potentially selected malignancies, as well as for the development of GIPR-targeted drugs.
Reference
Liskiewicz A, Müller TD. Regulation of energy metabolism through central GIPR signaling. Peptides. 2024 Jun;176:171198.
Samms RJ, Sloop KW, Gribble FM, Reimann F, Adriaenssens AE. GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders. Diabetes. 2021 Sep;70(9):1938-1944.
Morrow NM, Morissette A, Mulvihill EE. Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut. Peptides. 2024 Jun;176:171200.
Haase A, Alefeld E, Yalinci F, Meenen DV, Busch MA, Dünker N. Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells. Cancers. 2024; 16(9):1656.
Jonathan E. Campbell, Jacqueline L. Beaudry, Berit Svendsen, Laurie L. Baggio, Andrew N. Gordon, John R. Ussher, Chi Kin Wong, Fiona M. Gribble, David A. D’Alessio, Frank Reimann, Daniel J. Drucker; GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue. Diabetes 1 May 2022; 71 (5): 1115–1127.
변형 전략
The exon 3 to partial intron 3 of mouse Gipr was replaced with Exon 3~14 of Human GIPR CDS-3'UTR of Mouse Gipr-WPRE-BGH pA cassette. The murine signal peptide and aa.19 were preserved.

Figure 1. Gene editing strategy of B6-hGIPR mice.
응용 분야
GIPR-targeted drug screening, development, and evaluation;
Research on the pathological mechanisms and therapeutic approaches of metabolic and inflammatory diseases and potentially selected malignancies.
관련 자료
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
